Cargando…
T-cell co-stimulatory blockade in kidney transplantation: back to the bench
It is believed that blocking positive T-cell co-stimulatory pathways should lead to long-term graft acceptance. Despite the exciting initial achievements in experimental animal models, targeting co-stimulatory pathways has shown to be much more complex in the clinic. In addition to multiple binding...
Autores principales: | Riella, Leonardo V, Sayegh, Mohamed H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089598/ https://www.ncbi.nlm.nih.gov/pubmed/25018899 http://dx.doi.org/10.1038/kisup.2011.8 |
Ejemplares similares
-
Human genetics moves from clinic to bench - and back
por: Ogorelkova, Miroslava, et al.
Publicado: (2005) -
Bcl-2 antagonists and cancer: from the clinic, back to the bench
por: Esposti, M Degli
Publicado: (2010) -
Not transplanting kidney donors with acute kidney injury: a missed opportunity?
por: Murakami, Naoka, et al.
Publicado: (2019) -
Co-Stimulatory Blockade of the CD28/CD80-86/CTLA-4 Balance in Transplantation: Impact on Memory T Cells?
por: Ville, Simon, et al.
Publicado: (2015) -
The Association Between Viral Infections and Co-stimulatory Gene Polymorphisms in Kidney Transplant Outcomes
por: Niknam, Ahmad, et al.
Publicado: (2016)